TrialThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

C D Tweed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.